Micro
Emerging
Active
RADX 新型成像小分子
新的叙述，覆盖范围有限 — 仍在形成中。
评分
0.2
动能
▲ 0.0
文章
1
来源
1
热门股
| 股票代码 | 板块 | 变动 |
|---|---|---|
| Healthcare | +5.4% |
情绪时间线
板块表现
股票表现
事件时间线
假设
Pending
到期: 2027年4月7日
Radiopharm Theranostics will announce RAD101 adoption at minimum 5 major hospital networks or imaging centers within 12 months post-Siemens deal, indicating successful commercial penetration and clinical validation.
Pending
到期: 2026年7月6日
RPTX stock price will appreciate by minimum 20% within 90 days of Siemens supply deal announcement as market recognizes expanded commercial distribution and revenue visibility for RAD101 imaging product.
Pending
到期: 2026年10月4日
The Siemens Healthineers supply agreement for RAD101 will drive Radiopharm Theranostics' revenue growth by at least 15% YoY within 12 months following deal announcement, as evidenced by increased imaging procedure volume and market adoption.
热门股
| 股票代码 | 板块 | 变动 |
|---|---|---|
| Healthcare | +5.4% |
时间线
首次发现四月 07, 2026
最后更新四月 07, 2026